Lisa Burgess and her son Ben, 24, have relied on long-distance running for nearly a decade to process their grief and find ...

The state Department of Public Health held a public hearing regarding plans to reduce the level of maternity services at ...

With an additional 50 percent tariff on Chinese imports, the price tag on a pair of Framingham-based Topo shoes could ...

The developer of a proposed golf course in a wooded area in Framingham said he's hoping to raise up to $8 million to fund ...

FRAMINGHAM, MASS. (WHDH) - An aluminum products store in Framingham on Hollis Street is boarded up after a car slammed into it around 11 a.m. on Friday. Surveillance video from across the street ...

Paris: Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific ...

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to acquire the latter’s investigational bispecific antibody DR-0201.

Sanofi (NASDAQ:SNY) has agreed to acquire an immunology drug from clinical-stage biopharmaceutical company Dren Bio for up to $1.9B. The French pharmaceutical company will acquire DR-0201, a CD20 ...

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front Paris, ...

Sanofi (NASDAQ:SNY) has struck a major deal to acquire Dren Bio’s autoimmune disease treatment, DR-0201, reinforcing its expansion in the biopharmaceutical sector. The French healthcare giant ...

Sanofi said it would acquire Bispecific Myeloid Cell Engager, an autoimmune disease treatment, from Dren Bio, for up to $1.9 billion. The French pharmaceutical company on Thursday said it would ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...